摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide

中文名称
——
中文别名
——
英文名称
1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide
英文别名
1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl}methanesulfonamide;1,1,1-trifluoro-N-[(3R,4S)-3-hydroxy-2,2-dimethyl-4-(2-phenylethylamino)-3,4-dihydrochromen-7-yl]methanesulfonamide
1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide化学式
CAS
——
化学式
C20H23F3N2O4S
mdl
——
分子量
444.475
InChiKey
MBXIYTWDNALQLN-ZWKOTPCHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    96
  • 氢给体数:
    3
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide顺丁烯二酸乙醇 为溶剂, 以to obtain 1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl}methanesulfonamide maleate (yield: 65%)的产率得到1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide maleate
    参考文献:
    名称:
    Benzopyran Compound
    摘要:
    本发明涉及式(I)的苯并吡喃化合物,其中X为NR6,Y为键,SO或SO2,Z为C1-4烷基或苯基,W为氢原子,羟基,C1-6烷氧基,卤素原子,C1-4烷基或C1-6烷基磺酰氨基,R1和R2分别为C1-3烷基,R3为氢原子,羟基或甲氧基,m为0至4的整数,n为0至4的整数,V为单键,CR7R8,NR9,O,S,SO或SO2,R4为氢原子或C1-6烷基,R5为氢原子,C1-6烷基,C3-8环烷基,C3-8环烯基,C6-14芳基或C2-9杂芳基。这些化合物可用作抗心律失常剂。
    公开号:
    US20070299130A1
  • 作为产物:
    描述:
    t-butyl (2-phenylethyl) (3R*,4S*)-3-hydroxy-2,2-dimethyl-7-{(trifluoromethyl)sulfonyl amino}-3,4-dihydro-2H-benzopyran-4-yl carbamate盐酸sodium hydroxide 作用下, 以 1,4-二氧六环乙酸乙酯 为溶剂, 以91%的产率得到1,1,1-trifluoro-N-{(3R*,4S*)-3-hydroxy-2,2-dimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-benzopyran-7-yl} methanesulfonamide
    参考文献:
    名称:
    [EN] BENZOPYRAN COMPOUND USEFUL FOR THE TREATMENT OF ARRHYTMIA
    [FR] COMPOSÉ DE BENZOPYRANE
    摘要:
    公开号:
    WO2005080368A3
点击查看最新优质反应信息

文献信息

  • Benzopyran Compound
    申请人:Tsukagoshi Toru
    公开号:US20070299130A1
    公开(公告)日:2007-12-27
    This invention relates to benzopyran compounds of formula (I) wherein X is NR 6 , Y is a bond, SO or SO 2 , Z is C 1-4 alkyl group or phenyl group, W is hydrogen atom, hydroxy group, C 1-6 alkoxy group, a halogen atom, C 1-4 alkyl group or C 1-6 alkylsulfonylamino group, R 1 and R 2 are independently of each other C 1-3 alkyl group, R 3 is hydrogen atom, hydroxy group or methoxy group, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR 7 R 8 , NR 9 , O, S, SO or SO 2 , R 4 is hydrogen atom or C 1-6 alkyl group, R 5 is hydrogen atom, C 1-6 alkyl group, C 3-8 cycloalkyl group, C 3-8 cycloalkenyl group, C 6-14 aryl group or C 2-9 heteroaryl group. These compounds are useful as an anti-arrhythmic agent.
    本发明涉及式(I)的苯并吡喃化合物,其中X为NR6,Y为键,SO或SO2,Z为C1-4烷基或苯基,W为氢原子,羟基,C1-6烷氧基,卤素原子,C1-4烷基或C1-6烷基磺酰氨基,R1和R2分别为C1-3烷基,R3为氢原子,羟基或甲氧基,m为0至4的整数,n为0至4的整数,V为单键,CR7R8,NR9,O,S,SO或SO2,R4为氢原子或C1-6烷基,R5为氢原子,C1-6烷基,C3-8环烷基,C3-8环烯基,C6-14芳基或C2-9杂芳基。这些化合物可用作抗心律失常剂。
  • Benzopyran compounds useful for the treatment of arrhytmia
    申请人:Nissan Chemical Industries, Ltd.
    公开号:EP1718629B1
    公开(公告)日:2012-12-26
  • US7781483B2
    申请人:——
    公开号:US7781483B2
    公开(公告)日:2010-08-24
  • [EN] BENZOPYRAN COMPOUND USEFUL FOR THE TREATMENT OF ARRHYTMIA<br/>[FR] COMPOSÉ DE BENZOPYRANE
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2005080368A3
    公开(公告)日:2005-11-10
  • Benzopyran compound
    申请人:Nissan Chemical Industries, Ltd.
    公开号:US07781483B2
    公开(公告)日:2010-08-24
    This invention relates to benzopyran compounds of formula (I) wherein X is NR6, Y is a bond, SO or SO2, Z is C1-4alkyl group or phenyl group, W is hydrogen atom, hydroxy group, C1-6 alkoxy group, a halogen atom, C1-4alkyl group or C1-6alkylsulfonylamino group, R1 and R2 are independently of each other C1-3alkyl group, R3 is hydrogen atom, hydroxy group or methoxy group, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R4 is hydrogen atom or C1-6alkyl group, R5 is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, C6-14aryl group or C2-9heteroaryl group. These compounds are useful as an anti-arrhythmic agent.
    本发明涉及公式(I)的苯并吡喃化合物,其中X为NR6,Y为键,SO或SO2,Z为C1-4烷基或苯基,W为氢原子,羟基,C1-6烷氧基,卤原子,C1-4烷基或C1-6烷基磺酰氨基,R1和R2分别为C1-3烷基,R3为氢原子,羟基或甲氧基,m为0至4的整数,n为0至4的整数,V为单键,CR7R8,NR9,O,S,SO或SO2,R4为氢原子或C1-6烷基,R5为氢原子,C1-6烷基,C3-8环烷基,C3-8环烯基,C6-14芳基或C2-9杂环芳基。这些化合物可用作抗心律失常剂。
查看更多